Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948152 · ClinicalTrials.gov registry record · NA
A Study to Determine Preferences Towards Interface Products
A NA study of Sleep Disorder; Breathing-Related, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 5
- Study locations
NCT03948152 is a NA study of Sleep Disorder; Breathing-Related that has completed, run by Philips Respironics. The registered enrollment target is 310 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT03948152, a NA study of Sleep Disorder; Breathing-Related, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 5
- Study locations
Study Summary
Enrolled Naïve participants will be randomized to one of two arms, the investigational or control arm. Once randomized the institutions will fit the participant with the procedures outlined in the protocol. Each participant will be required to trial the mask for a period of 90 days. Any Unscheduled Visits or Calls that occur during the participants 90 days documented.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Mask Advice Tool
Study Locations (5)
Florida
- Pulmonary Disease Specialists, PA, d/b/a PDS Research - Kissimmee
Maryland
- Center for Sleep and Wake Disorders - Chevy Chase
Ohio
- Pullmonary Rehabilition Associates - Youngstown
Pennsylvania
- Berks Schuylkill Respiratory Specialists, Ltd. - Reading
South Carolina
- Bogan Sleep Consultants, LLC - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2020-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03948152
The ClinicalTrials.gov registry entry for NCT03948152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Disorder; Breathing-Related appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT03948152 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Maryland, Ohio.
Frequently Asked Questions
What is clinical trial NCT03948152 about?
NCT03948152 is a clinical study titled "A Study to Determine Preferences Towards Interface Products". Enrolled Naïve participants will be randomized to one of two arms, the investigational or control arm. Once randomized the institutions will fit the participant with the procedures outlined in the protocol. Each participant will be required to trial the mask for a period of 90 days. Any Unscheduled ...
What is the current status of trial NCT03948152?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2019-04-18. Estimated completion is 2020-02-07.
What conditions does trial NCT03948152 study?
This clinical trial studies the following conditions: Sleep Disorder; Breathing-Related.
What interventions are being tested in trial NCT03948152?
The interventions under investigation include: Standard of Care (OTHER), Mask Advice Tool (OTHER).
Who is sponsoring clinical trial NCT03948152?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03948152 being conducted?
This trial has 5 study locations across Florida, Maryland, Ohio, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder; Breathing-Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.